Retarded release phosphatidylcholine ( DrugBank: Phosphatidylcholine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
97	Ulcerative colitis	4

97. Ulcerative colitis

---

Clinical trials : 2,630 /  Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00259558 (ClinicalTrials.gov)	April 2003	25/11/2005	Dose Finding Study for Retarded Phosphatidylcholine in Pancolitis	Prospektive, Randomisierte Doppelblinde Studie Zur Dosisfindung Von Intestinal Redardiert Freigesetztem Phosphatidylcholin Bei Chronisch Aktiver Pancolitis Ulcerosa	Ulcerative Colitis	Drug: retarded release phosphatidylcholine	Heidelberg University	Prof. Wolfgang Stremmel;Dietmar Hopp Stiftung	Completed	16 Years	90 Years	Both	60	Phase 2	Germany
2	NCT00259571 (ClinicalTrials.gov)	April 2003	28/11/2005	Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.	Prospektive, Randomisierte, Doppelblinde, Mesalazin-kontrollierte (Double-dummy Verfahren) Multizenter-Studie Zur Beurteilung Der Annahme Der äquivalenten Wirkung Von Intestinal Retardiert Freigesetztem Phosphatidylcholin gegenüber Mesalazin (Non-inferiority Study) in Der Remissionserhaltung Der Colitis Ulcerosa.	Ulcerative Colitis	Drug: retarded release phosphatidylcholine	Heidelberg University	Dietmar Hopp Stiftung	Withdrawn	15 Years	80 Years	Both	0	Phase 2/Phase 3	Germany
3	NCT00259545 (ClinicalTrials.gov)	February 2003	25/11/2005	Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis	Prospektive, Randomisierte Doppelblinde Studie Zur Wirksamkeit Von Intestinal Retardiert Freigesetztem Phosphatidylcholine Bei therapierefraktärer Colitis Ulcerosa Mit Chronisch Aktivem Verlauf Unter Corticosteroiden	Ulcerative Colitis;Phosphatidylcholine	Drug: Retarded Release Phosphatidylcholine (rPC)	Heidelberg University	Professor Wolfgang Stremmel;Dietmar Hopp Stiftung	Completed	16 Years	90 Years	Both	60	Phase 2	Germany
4	NCT00463619 (ClinicalTrials.gov)	April 2000	18/4/2007	Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis		Ulcerative Colitis	Drug: Retarded release phosphatidylcholine	Heidelberg University	NULL	Completed	16 Years	N/A	Both	132	N/A	Germany